Work

Intergroup RTOG 98–11: A phase III randomized study of 5-fluorouracil (5-FU), mitomycin, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.4009

Authors: J. A. Ajani, K. A. Winter, L. L. Gunderson, J. Pedersen, A. B. Benson, C. Thomas, R. J. Mayer, M. G. Haddock, C. Willett, C. Willett, T. A. Rich

Institutions: Northwestern University, Mayo Clinic, The University of Texas MD Anderson Cancer Center, University of Alberta, RTOG Foundation, Dana-Farber Cancer Institute, Mayo Clinic in Arizona, Duke Medical Center, University of Virginia Medical Center

Language: English

Topic: Colorectal and Anal Carcinomas

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1867572965

Cites:

Cited by: 52

Related to: 10